ANA E CORTEGUERA
Allopathic & Osteopathic Physicians|Family Medicine SUGAR LAND, TX NPI 1699700765
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine TX Abbott Laboratories All categories
General Payments — all program years on this page
$7,115.03
- Category: General Payments
- Program years: PY2018–2024
- Record count: 392
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,038.98 across 106 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,038.98 | 106 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $407.74 | 21 |
| Novo Nordisk AS | $359.25 | 16 |
| PFIZER INC. | $197.77 | 11 |
| GlaxoSmithKline, LLC. | $170.70 | 12 |
| SHIELD THERAPEUTICS INC | $139.90 | 6 |
| Acerta Pharma LLC | $112.38 | 7 |
| ABBVIE INC. | $93.03 | 4 |
| Merck Sharp & Dohme Corporation | $70.17 | 4 |
| IBSA Pharma Inc. | $68.20 | 4 |
| Lilly USA, LLC | $64.63 | 3 |
| Astellas Pharma US Inc | $57.58 | 2 |
| Amgen Inc. | $48.29 | 3 |
| Inspire Medical Systems, Inc. | $39.86 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.38 | 2 |
| SANOFI-AVENTIS U.S. LLC | $24.99 | 1 |
| Alvogen Inc | $20.05 | 1 |
| Exact Sciences Corporation | $19.75 | 1 |
| DEXCOM, INC. | $19.21 | 1 |
| Azurity Pharmaceuticals, Inc. | $19.12 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.92 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.68 | 1 |
| OptiNose US, Inc. | $17.20 | 1 |
| Currax Pharmaceuticals LLC | $17.18 | 1 |
By program year
Records — PY2024 (106)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.